US Stock MarketDetailed Quotes
RBOT Vicarious Surgical
- 11.490
- +1.200+11.66%
Close Nov 22 16:00 ET
67.89MMarket Cap-1113P/E (TTM)
11.600High10.290Low37.81KVolume10.290Open10.290Pre Close411.78KTurnover1.21%Turnover RatioLossP/E (Static)5.91MShares21.42652wk High1.17P/B35.81MFloat Cap4.27052wk Low--Dividend TTM3.12MShs Float473.565Historical High--Div YieldTTM12.73%Amplitude4.270Historical Low10.891Avg Price1Lot Size
Vicarious Surgical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 26.58%-12.69M | 26.93%-11.02M | 22.14%-14.46M | -1.79%-62.31M | 38.24%-11.37M | -24.91%-17.28M | -6.22%-15.08M | -25.75%-18.57M | -83.83%-61.21M | -88.75%-18.41M |
| Net income from continuing operations | -8.83%-17.09M | 0.84%-15.21M | 36.85%-17M | -1,478.15%-71.07M | -17.27%-13.11M | 36.52%-15.7M | -955.33%-15.33M | -163.31%-26.92M | 114.65%5.16M | -151.32%-11.18M |
| Operating gains losses | 102.23%105K | 69.40%-1.56M | -69.29%1.87M | 93.82%-5.19M | 82.94%-1.49M | -254.81%-4.7M | 71.13%-5.08M | 110.01%6.08M | -2,629.93%-84M | 78.01%-8.71M |
| Depreciation and amortization | 13.42%507K | 21.77%537K | 18.14%521K | 66.88%1.85M | 30.60%525K | 32.25%447K | 137.10%441K | 138.38%441K | 251.58%1.11M | 219.05%402K |
| Other non cash items | 133.23%109K | 226.56%81K | -1,025.93%-250K | -146.24%-418K | -121.81%-53K | -256.94%-328K | -128.19%-64K | -88.00%27K | 4,204.76%904K | 1,720.00%243K |
| Change In working capital | 222.17%744K | 25.92%2.06M | -85.37%-2.69M | -122.19%-746K | 88.21%-320K | -116.61%-609K | -1.81%1.63M | -293.98%-1.45M | 252.04%3.36M | -151.63%-2.71M |
| -Change in prepaid assets | 184.39%611K | -73.77%282K | -133.55%-209K | 111.62%1.42M | 31.56%446K | 67.33%-724K | -29.88%1.08M | -38.62%623K | 114.56%671K | -74.16%339K |
| -Change in payables and accrued expense | 15.81%359K | 172.75%2.06M | -24.10%-2.25M | -170.75%-1.31M | 80.00%-563K | -93.58%310K | 181.04%756K | -315.86%-1.81M | -61.79%1.85M | -174.45%-2.82M |
| -Change in other current assets | 26.47%43K | -208.00%-27K | 107.96%9K | 76.09%-22K | 134.78%32K | --34K | --25K | ---113K | ---92K | ---92K |
| -Change in other current liabilities | -17.47%-269K | -16.96%-262K | -60.67%-241K | -189.43%-838K | -60.96%-235K | -121.69%-229K | -60.00%-224K | -189.82%-150K | --937K | ---146K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 26.58%-12.69M | 26.93%-11.02M | 22.14%-14.46M | -1.79%-62.31M | 38.24%-11.37M | -24.91%-17.28M | -6.22%-15.08M | -25.75%-18.57M | -83.83%-61.21M | -88.75%-18.41M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 23.60%-492K | -9.36%-6.95M | 99.67%-144K | -755.44%-45.78M | 608.57%5.05M | 17.65%-644K | -308.48%-6.36M | -2,067.56%-43.83M | -315.21%-5.35M | -14.42%-992K |
| Net PPE purchase and sale | 126.27%31K | 97.12%-6K | 96.73%-10K | 68.80%-1.67M | -4.64%-1.04M | 84.91%-118K | 86.63%-208K | 84.87%-306K | -315.21%-5.35M | -14.42%-992K |
| Net investment purchase and sale | 0.57%-523K | -12.96%-6.95M | 99.69%-134K | ---44.11M | --6.08M | ---526K | ---6.15M | ---43.52M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 23.60%-492K | -9.36%-6.95M | 99.67%-144K | -755.44%-45.78M | 608.57%5.05M | 17.65%-644K | -308.48%-6.36M | -2,067.56%-43.83M | -315.21%-5.35M | -14.42%-992K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | -99.27%2K | 388.81%44.7M | -99.61%34K | 44,133.00%44.23M | 174.58%162K | 56.90%273K | -95.24%9.15M | 1,913.17%8.81M |
| Net issuance payments of debt | --0 | --0 | --0 | 98.85%-16K | --0 | --0 | 97.53%-4K | 92.59%-12K | -207.21%-1.4M | -462.96%-912K |
| Net common stock issuance | --0 | ---- | ---- | 372.45%47.25M | --0 | --47.05M | ---- | ---- | --10M | --10M |
| Proceeds from stock option exercised by employees | --0 | --0 | -97.65%2K | -64.85%296K | 41.67%34K | -95.79%11K | -24.89%166K | -74.70%85K | 92.68%842K | -92.55%24K |
| Net other financing activities | ---- | ---- | ---- | -841.00%-2.82M | --0 | ---- | ---- | --200K | -100.16%-300K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | -99.27%2K | 388.81%44.7M | -99.61%34K | 44,133.00%44.23M | 174.58%162K | 56.90%273K | -95.24%9.15M | 1,913.17%8.81M |
| Net cash flow | ||||||||||
| Beginning cash position | -37.21%21.19M | -28.83%39.16M | -54.11%53.76M | -32.89%117.14M | -52.99%60.05M | -76.28%33.74M | -65.17%55.02M | -32.89%117.14M | 927.74%174.56M | -31.20%127.73M |
| Current changes in cash | -150.11%-13.18M | 15.53%-17.97M | 76.50%-14.6M | -10.39%-63.39M | 40.59%-6.29M | 281.20%26.31M | -35.55%-21.28M | -273.91%-62.13M | -136.44%-57.42M | 4.66%-10.59M |
| End cash Position | -86.67%8.01M | -37.21%21.19M | -28.83%39.16M | -54.11%53.76M | -54.11%53.76M | -52.99%60.05M | -76.28%33.74M | -65.17%55.02M | -32.89%117.14M | -32.89%117.14M |
| Free cash flow | 27.17%-12.67M | 27.88%-11.03M | 23.35%-14.47M | 3.89%-63.98M | 36.04%-12.41M | -19.04%-17.4M | 2.95%-15.29M | -12.43%-18.88M | -92.45%-66.56M | -82.68%-19.4M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
